Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models …

Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ …

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

Absci is a data-first generative AI drug creation company unlocking novel biology through generative AI. Our Integrated Drug Creation™ Platform powers cutting-edge de novo AI and …

3 天之前 · Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and …

VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today …

2025年3月18日 · About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

2025年3月18日 · Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ETCompany ParticipantsAlex Khan - VP of Finance and IRSean McClain -...

2024年12月12日 · Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

2025年3月21日 · Get a real-time Absci Corporation (ABSI) stock price with an overview of financials, statistics, forecasts, charts and more.